Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidde J Haisma

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammationInês F Antunes, Janine Doorduin, Hidde J Haisma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable moleculeTheron S Johnson, Karsten Mahnke, Volker Storn, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathwaysMarieke H Schoemaker, Laura Conde de la Rosa, Manon Buist-Homan, et al.
Molecular Carcinogenesis|December 23, 2006
Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein-2 promoter as a novel anti-cancer treatmentWillemijn M Gommans, Pamela M J McLaughlin, Beatrice I Lindhout, et al.
Molecular Pharmaceutics|September 27, 2012
Induction of β-glucuronidase release by cytostatic agents in small tumorsInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapyAnne Rixt Buursma, Antoine M J Beerens, Erik F J de Vries, et al.
Gynecologic Oncology|October 18, 2005
Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapyParameshwar J Mahasreshti, Manjula Kataram, Hongju Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicityParameshwar J Mahasreshti, Manjula Kataram, Ming H Wang, et al.
Nuclear Medicine and Biology|March 27, 2012
In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent modelInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Biochemical Pharmacology|January 1, 2016
The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylasesThea van den Bosch, Alexander Boichenko, Niek G J Leus, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammationInês F Antunes, Janine Doorduin, Hidde J Haisma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable moleculeTheron S Johnson, Karsten Mahnke, Volker Storn, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathwaysMarieke H Schoemaker, Laura Conde de la Rosa, Manon Buist-Homan, et al.
Molecular Carcinogenesis|December 23, 2006
Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein-2 promoter as a novel anti-cancer treatmentWillemijn M Gommans, Pamela M J McLaughlin, Beatrice I Lindhout, et al.
Molecular Pharmaceutics|September 27, 2012
Induction of β-glucuronidase release by cytostatic agents in small tumorsInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapyAnne Rixt Buursma, Antoine M J Beerens, Erik F J de Vries, et al.
Gynecologic Oncology|October 18, 2005
Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapyParameshwar J Mahasreshti, Manjula Kataram, Hongju Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicityParameshwar J Mahasreshti, Manjula Kataram, Ming H Wang, et al.
Nuclear Medicine and Biology|March 27, 2012
In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent modelInês F Antunes, Hidde J Haisma, Philip H Elsinga, et al.
Biochemical Pharmacology|January 1, 2016
The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylasesThea van den Bosch, Alexander Boichenko, Niek G J Leus, et al.
Pageof 8